Severe postoperative haemorrhage and airway obstruction following high-dose enoxaparin

Medical Journal of Australia

Volumn 175, Issue 3, 2001, Pages 167-168

  Wilson, M D ^a   Harrison, K ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; SEX HORMONE;

ADULT; AIRWAY OBSTRUCTION; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG CHOICE; DRUG INFUSION; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSPNEA; ENDOTRACHEAL INTUBATION; ERYTHROCYTE TRANSFUSION; EYELID RECONSTRUCTION; FACE EDEMA; FEMALE; FIBEROSCOPE; GENERAL ANESTHESIA; HEMOGLOBIN ANALYSIS; HORMONE SUBSTITUTION; HUMAN; INTENSIVE CARE UNIT; LARYNGOSCOPY; LUNG EMBOLISM; ORTHOSTATIC HYPOTENSION; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIVATE HOSPITAL; PROPHYLAXIS; RISK ASSESSMENT; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THROMBOCYTE COUNT; THROMBOEMBOLISM; TREATMENT OUTCOME; VEIN THROMBOSIS;

EID: 0035816920     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2001.tb143071.x     Document Type: Article

References (10)

1. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism
2. Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis
3. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis
4. A clinical trial of vena canal filters in the prevention of pulmonary embolism in patients with proximal deep vein thrombosis
5. Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin): Results of a double-blind randomised study
6. Identification of risk factors for bleeding during treatment of acute venous thromboembolism with heparin or low molecular weight heparin
7. The use of heparin in patients in whom pulmonary embolism is suspected after total hip arthroplasty
8. Complications of heparin therapy after total joint arthroplasty
9. Low molecular weight heparins: Current use and indications
10. Preparation and clinicl use of plasma and plasma fractions